President Trump wants to bring pharmaceutical manufacturing back to the U.S. Experts warn tariffs could result in shortages ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

The global molybdenum disilicide industry share is poised for substantial growth, with an anticipated valuation of USD 8.5 billion by 2032, representing a robust CAGR of 7.2% from 2022 to 2032. This ...

Because when exchange rates dictate the cost of medicines, they also quietly influence who can get medical treatment and who ...

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

Recently, Beijing Tsingke Biotech Co., Ltd. officially announced the appointment of Dr. Yaning Wang, a former senior expert ...

Slide in pharma shares as statement underscores how unpredictable and uncertain ‘Trump tariffs’ are going to be ...

Istat communicated that, a February 2025retail sales in Italy do not present significant variations compared to the previous month, with ...

Dr. Natália Bellan presents a sustainable model for pharmaceutical reindustrialization based on regulatory intelligence, applied science, technical education, and long-term state support—with ...

Switzerland's pharmaceutical industry wants to go green. But new figures reveal that where production happens, the ...

Indian drugmakers supply 47 per cent of the generic medicine requirements in the US, and tariffs would have increased prices ...